PMC:7278327 / 8753-8897 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T67","span":{"begin":134,"end":137},"obj":"Body_part"}],"attributes":[{"id":"A67","pred":"fma_id","subj":"T67","obj":"http://purl.org/sig/ont/fma/fma55675"}],"text":"Currently, however, there are no vaccines in development that are designed to specifically target or neutralize SARS-CoV-2 entry into CNS areas."}

{"project":"LitCovid-PubTator","denotations":[{"id":"295","span":{"begin":112,"end":122},"obj":"Species"}],"attributes":[{"id":"A295","pred":"tao:has_database_id","subj":"295","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Currently, however, there are no vaccines in development that are designed to specifically target or neutralize SARS-CoV-2 entry into CNS areas."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T70","span":{"begin":112,"end":120},"obj":"Disease"}],"attributes":[{"id":"A70","pred":"mondo_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Currently, however, there are no vaccines in development that are designed to specifically target or neutralize SARS-CoV-2 entry into CNS areas."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T110","span":{"begin":134,"end":137},"obj":"http://www.ebi.ac.uk/efo/EFO_0000302"},{"id":"T111","span":{"begin":134,"end":137},"obj":"http://www.ebi.ac.uk/efo/EFO_0000908"}],"text":"Currently, however, there are no vaccines in development that are designed to specifically target or neutralize SARS-CoV-2 entry into CNS areas."}

{"project":"LitCovid-sentences","denotations":[{"id":"T43","span":{"begin":0,"end":144},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Currently, however, there are no vaccines in development that are designed to specifically target or neutralize SARS-CoV-2 entry into CNS areas."}